AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 154 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $94,905,000 | -44.2% | 3,720 | -56.1% | 0.00% | – |
| Q2 2014 | $169,948,000 | -91.0% | 8,472 | -90.7% | 0.00% | -100.0% |
| Q4 2013 | $1,889,040,000 | +670.4% | 91,082 | +576.1% | 0.00% | – |
| Q3 2013 | $245,190,000 | -51.5% | 13,472 | -55.7% | 0.00% | – |
| Q2 2013 | $505,598,000 | – | 30,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,847,842 | $47,362,000 | 5.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,850,644 | $80,671,000 | 3.80% |
| KING INVESTMENT ADVISORS INC/TX | 491,465 | $8,174,000 | 3.39% |
| SECTOR GAMMA AS | 684,724 | $11,388,000 | 3.32% |
| Healthcare Value Capital, LLC | 274,481 | $4,565,000 | 3.31% |
| Broadfin Capital, LLC | 800,000 | $13,305,000 | 2.60% |
| Healthcare Value Capital, LLC | 150,000 | $2,495,000 | 1.81% |
| Artal Group S.A. | 2,637,200 | $43,859,000 | 1.38% |
| Proxima Capital Management, LLC | 355,722 | $5,916,000 | 1.37% |
| Manatuck Hill Partners, LLC | 414,000 | $6,885,000 | 0.84% |